Quantcast

Latest The New England Journal Stories

34298c152273302c62784c909997aec81
2011-03-31 08:38:00

By Jim Dryden, Washington University School of Medicine in St. Louis For obese seniors, dieting and exercise together are more effective at improving physical performance and reducing frailty than either alone. The research, by a team at Washington University School of Medicine in St. Louis, is reported March 31 in The New England Journal of Medicine. Older adults who are obese face severe health risks, including high blood pressure, heart disease and diabetes, which can be compounded by a...

2011-03-31 01:55:37

A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital. "This study represents a remarkable advance and a potential cure for people with hepatitis C who have not responded to previous therapy," says co-author Stuart C. Gordon, M.D., section chief for the Division of Hepatology at Henry Ford Hospital. "We will soon have a new standard of treatment for hepatitis C patients,"...

2011-02-24 15:35:55

Clinicians have often referred to ultrasound technology as the "stethoscope of the future," predicting that as the equipment shrinks in size, it will one day be as common at the bedside as that trusty tool around every physician's neck. According to a new report in The New England Journal of Medicine, that day has arrived. The "Current Concepts" article by Yale School of Medicine clinicians Christopher L. Moore, M.D., and Joshua A. Copel, M.D., outlines how ultrasound use has moved beyond...

2011-02-24 15:31:08

A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes. The study, led by Wei Zheng, M.D., Ph.D., M.P.H., Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, Nashville, Tenn., Paolo Boffetta, M.D., M.P.H., professor, Mount...

2011-02-17 12:48:36

A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity. The results of a multicenter clinical trial led by researchers at The University of Texas Health Science Center at Houston (UTHealth) are published in the Feb. 17 issue of The New England Journal of Medicine. Retinopathy of prematurity is a leading cause of childhood blindness worldwide. In the...

2011-02-02 20:52:24

Significantly reduces recurrence of infection, improves cure rates Clostridium difficile infection (CDI) is a significant and growing problem in hospitals and other health care facilities, but no new drugs to treat the condition have been developed in several decades. However, a large-scale, phase 3 trial conducted by Canadian and U.S. researchers shows that the new antibiotic Fidaxomicin is superior to existing treatments, demonstrating a 45 percent reduction in recurrences vs. the existing...

2011-02-02 12:15:00

SAN DIEGO, Feb. 2, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only...

2011-01-28 13:13:44

Studies published in the New England Journal of Medicine and JAMA within a week of each other The mystery began in 1976. Adolfo Pampena was diagnosed with a rare form of cancer that caused a strange combination of symptoms and was associated with the occurrence of multiple tumors in his stomach and colon. His medical team was stumped and was unable to answer the most important questions for him and his family: the cause of his disease and the risk for future generations. Now, 35 years later,...

2011-01-11 15:13:00

A worldwide research consortium that includes the University of Oklahoma Health Sciences Center has proven that a new drug is more effective and easier to use than current medicines in the prevention of blood clots following hip replacement surgery. The results reveal a better way to prevent the formation of blood clots in the deep veins of the legs "“ a condition known as deep vein thrombosis (DVT). The blood clots become life-threatening pulmonary embolisms (PE) when they break free...

2010-11-25 22:04:40

'Vaccine delivery to as-yet-unaffected parts of Haiti could help stabilize the country' In the wake of devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, a group of leading experts from Harvard Medical School, George Washington University, and the International Vaccine Institute (IVI) have urged the United States to create an emergency stockpile of cholera vaccines for future humanitarian use. "The costs to the U.S. of creating and maintaining a stockpile of several...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related